2002
DOI: 10.1034/j.1399-6576.2002.460104.x
|View full text |Cite
|
Sign up to set email alerts
|

Effective inhibition of nitric oxide production by aminoguanidine does not reverse hypotension in endotoxaemic rats

Abstract: AG inhibited NO formation in a dose-dependent way. Yet, AG had no haemodynamic effects, suggesting a minor cardiovascular influence of iNOS in this endotoxin model, in parallel to what has been found in microbial sepsis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
1

Year Published

2003
2003
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 32 publications
1
10
1
Order By: Relevance
“…Although tachycardia during shock has been observed in some studies [8,28], bradycardia has been observed by others [29,30]. In the present study, there was no observed change in HR during LPSinduced shock, providing no evidence that a change in sympathetic stimulation to the heart is responsible for the decrease in stroke volume.…”
Section: Discussioncontrasting
confidence: 52%
See 2 more Smart Citations
“…Although tachycardia during shock has been observed in some studies [8,28], bradycardia has been observed by others [29,30]. In the present study, there was no observed change in HR during LPSinduced shock, providing no evidence that a change in sympathetic stimulation to the heart is responsible for the decrease in stroke volume.…”
Section: Discussioncontrasting
confidence: 52%
“…Several studies have demonstrated that the transient phase of in vivo hypotension observed during endotoxic shock is mediated via a pathway independent of nitric oxide or prostaglandin formation [7][8][9]. Recently, it has been observed that potassium channels activated in arterial smooth muscle cause hyperpolarization in vitro when exposed to LPS [4,6,18].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In these experiments, four TDS groups (aged-matched with the TDS study above) received one daily injection of either the selective iNOS inhibitor, aminoguanidine (AG; 50 mg/kg/day i.p. ; Metcalf et al 2002), the selective nNOS inhibitor, 7-nitroindazole (7-NI; 12.5 mg/kg/day i.p. ; Ikeda et al 1998), the steroid synthesis inhibitor, ketokonazole (KCZ; 24 mg/kg/day i.p.…”
Section: Treatment Groupsmentioning
confidence: 99%
“…These observations were further strengthened when a recent study suggested that the anti-oxidant property of aminoguanidine might have an anti-aging effect on cultured fibroblasts [43]. Other roles of aminoguanidine include inhibiting nonenzymatic glycosylation [44], polyamine formation and NO production [45]. Though the medium used in our studies has 5.6 mM glucose (comparable to serum glucose levels), sequestration of epidermis from serum might mean that this level is still too high.…”
Section: Discussionmentioning
confidence: 69%